These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
308 related articles for article (PubMed ID: 16178132)
1. Efficacy of a high bioavailable cetylpyridinium chloride mouthrinse over a 24-hour period: a plaque imaging study. Kozak KM; Gibb R; Dunavent J; White DJ Am J Dent; 2005 Jul; 18 Spec No():18A-23A. PubMed ID: 16178132 [TBL] [Abstract][Full Text] [Related]
2. The effect of toothbrushing regimens on the plaque inhibitory properties of an experimental cetylpyridinium chloride mouthrinse. Witt J; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A J Clin Periodontol; 2006 Oct; 33(10):737-42. PubMed ID: 16899026 [TBL] [Abstract][Full Text] [Related]
3. In vivo antiplaque efficacy of combined antimicrobial dentifrice and rinse hygiene regimens. White DJ; Barker ML; Klukowska M Am J Dent; 2008 Jun; 21(3):189-96. PubMed ID: 18686773 [TBL] [Abstract][Full Text] [Related]
4. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in preventing dental plaque. Lotufo R; Calil CM; Feng HS; Sekiguchi RT; Stewart B; DeVizio W; Proskin HM J Clin Dent; 2009; 20(2):50-4. PubMed ID: 19591337 [TBL] [Abstract][Full Text] [Related]
5. Clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride in reducing dental plaque. Hernandez-Cott PL; Elias Boneta A; Stewart B; DeVizio W; Proskin HM J Clin Dent; 2009; 20(2):39-44. PubMed ID: 19591335 [TBL] [Abstract][Full Text] [Related]
6. A clinical investigation of the efficacy of a commercial mouthrinse containing 0.05% cetylpyridinium chloride to control established dental plaque and gingivitis. Silva MF; dos Santos NB; Stewart B; DeVizio W; Proskin HM J Clin Dent; 2009; 20(2):55-61. PubMed ID: 19591338 [TBL] [Abstract][Full Text] [Related]
7. Antibacterial and antiplaque effects of a novel, alcohol-free oral rinse with cetylpyridinium chloride. Witt J; Ramji N; Gibb R; Dunavent J; Flood J; Barnes J J Contemp Dent Pract; 2005 Feb; 6(1):1-9. PubMed ID: 15719071 [TBL] [Abstract][Full Text] [Related]
8. A 6-month clinical trial to study the effects of a cetylpyridinium chloride mouthrinse on gingivitis and plaque. Mankodi S; Bauroth K; Witt JJ; Bsoul S; He T; Gibb R; Dunavent J; Hamilton A Am J Dent; 2005 Jul; 18 Spec No():9A-14A. PubMed ID: 16178130 [TBL] [Abstract][Full Text] [Related]
9. A randomized, double-blind clinical study to assess the antimicrobial effects of a cetylpyridinium chloride mouth rinse on dental plaque bacteria. Hu D; Li X; Sreenivasan PK; DeVizio W Clin Ther; 2009 Nov; 31(11):2540-8. PubMed ID: 20109998 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of the antiplaque efficacy of two cetylpyridinium chloride-containing mouthwashes. Barnes VM; Arvanitidou E; Szewczyk G; Richter R; DeVizio W; Cronin M; Michelle S J Clin Dent; 2011; 22(6):200-3. PubMed ID: 22403976 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of a mouthrinse containing 0.05% cetylpyridinium chloride for the control of plaque and gingivitis: a 6-month clinical study in adults. Allen DR; Davies R; Bradshaw B; Ellwood R; Simone AJ; Robinson R; Mukerjee C; Petrone ME; Chaknis P; Volpe AR; Proskin HM Compend Contin Educ Dent; 1998; 19(2 Suppl):20-6. PubMed ID: 10371878 [TBL] [Abstract][Full Text] [Related]
12. A randomized clinical trial to compare plaque inhibition of a sodium fluoride/potassium nitrate dentifrice versus a stabilized stannous fluoride/sodium hexametaphosphate dentifrice. Bellamy PG; Khera N; Day TN; Barker ML; Mussett AJ J Contemp Dent Pract; 2009 Mar; 10(2):1-9. PubMed ID: 19279966 [TBL] [Abstract][Full Text] [Related]
13. A clinical study to assess the 12-hour antimicrobial effects of cetylpyridinium chloride mouthwashes on supragingival plaque bacteria. He S; Wei Y; Fan X; Hu D; Sreenivasan PK J Clin Dent; 2011; 22(6):195-9. PubMed ID: 22403975 [TBL] [Abstract][Full Text] [Related]
14. Superiority of an essential oil mouthrinse when compared with a 0.05% cetylpyridinium chloride containing mouthrinse: a six-month study. Sharma NC; Araujo MW; Wu MM; Qaqish J; Charles CH Int Dent J; 2010 Jun; 60(3):175-80. PubMed ID: 20684443 [TBL] [Abstract][Full Text] [Related]
15. Practice implications with an alcohol-free, 0.07% cetylpyridinium chloride mouthrinse. Blenman TV; Morrison KL; Tsau GJ; Medina AL; Gerlach RW Am J Dent; 2005 Jul; 18 Spec No():29A-34A. PubMed ID: 16178134 [TBL] [Abstract][Full Text] [Related]
16. Comparative clinical trial of two antigingivitis mouthrinses. Witt JJ; Walters P; Bsoul S; Gibb R; Dunavent J; Putt M Am J Dent; 2005 Jul; 18 Spec No():15A-17A. PubMed ID: 16178131 [TBL] [Abstract][Full Text] [Related]
17. Effect of a stannous fluoride dentifrice on plaque formation and removal: a digital plaque imaging study. White DJ J Clin Dent; 2007; 18(1):21-4. PubMed ID: 17410952 [TBL] [Abstract][Full Text] [Related]
18. A 24-hour dental plaque prevention study with a stannous fluoride dentifrice containing hexametaphosphate. White DJ; Kozak KM; Gibb R; Dunavent J; Klukowska M; Sagel PA J Contemp Dent Pract; 2006 Jul; 7(3):1-11. PubMed ID: 16820802 [TBL] [Abstract][Full Text] [Related]
19. An alcohol-free therapeutic mouthrinse with cetylpyridinium chloride (CPC)--the latest advance in preventive care: Crest Pro-Health Rinse. White DJ Am J Dent; 2005 Jul; 18 Spec No():3A-8A. PubMed ID: 16178129 [No Abstract] [Full Text] [Related]